| CAS No 123318-82-1 |
(2R,3R,4S, 5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol98% |
Inquiry |
| CAS No 320-67-2 |
5-Azacytidine98% |
Inquiry |
| CAS No 2353-33-5 |
5-Aza-2'-deoxycytidine98% |
Inquiry |
| CAS No 60933-68-8 |
3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-ol98% |
Inquiry |
| CAS No 52522-49-3 |
2,3,5-Tri-O-benzyl-D-arabinofuranose 1-(4-nitrobenzoate)98% |
Inquiry |
| CAS No 153186-10-8 |
1,2-O-(1-methylethylidene)-4-C-[(phenylmethoxy)methyl]-3-O-(phenylmethyl)-L-Lyxofuranose98% |
Inquiry |
| CAS No 63593-03-3 |
a-D-erythro-Pentofuranose,4-C-(hydroxymethyl)-1,2-O-(1-methylethylidene)-3-O-(phenylmethyl)-98% |
Inquiry |
| CAS No 144490-03-9 |
[(2S,3S,4S,5R)-3,4,5-triacetyloxyoxolan-2-yl]methyl acetate98% |
Inquiry |
| CAS No 13035-61-5 |
[(2R,3R,4R,5S)-3,4,5-triacetyloxyoxolan-2-yl]methyl acetate98% |
Inquiry |
| CAS No 171721-00-9 |
1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-alpha-L-arabinofuranosenull |
Inquiry |
| CAS No 97614-43-2 |
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-D-ribofuranose98% |
Inquiry |
| CAS No 171866-30-1 |
1,3,5-tri-o-benzoyl-alpha-l-ribofuranose98% |
Inquiry |
| CAS No 22224-41-5 |
1,3,5-Tri-O-benzoyl-D-ribofuranose98% |
Inquiry |
| CAS No 3080-30-6 |
b-L-Ribofuranose, 1-acetate2,3,5-tribenzoate98% |
Inquiry |
| CAS No 6974-32-9 |
[(2R,3R,4R,5S)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate98% |
Inquiry |
| CAS No 609-06-3 |
L-(-)-Xylosenull |
Inquiry |
| CAS No 50-69-1 |
D-Ribose98% |
Inquiry |
| CAS No 1214-39-7 |
N-benzyl-7H-purin-6-aminenull |
Inquiry |
| CAS No 767-69-1 |
6-bromo-7H-purine98% |
Inquiry |
| CAS No 2365-40-4 |
N-(3-methylbut-2-enyl)-7H-purin-6-amine98% |
Inquiry |
| CAS No 1637-39-4 |
(E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol98% |
Inquiry |
| CAS No 21047-89-2 |
2-methyl-N-(6-oxo-3,7-dihydropurin-2-yl)propanamide98% |
Inquiry |
| CAS No 4005-49-6 |
N-(7H-purin-6-yl)benzamide98% |
Inquiry |
| CAS No 3056-33-5 |
N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide98% |
Inquiry |
| CAS No 73-24-5 |
7H-purin-6-amine98% |
Inquiry |
